- Home
- VOD vs BDX Comparison
VOD vs BDX Comparison
Compare VOD & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOD | BDX |
|---|---|---|
| Founded | 1984 | 1897 |
| Country | United Kingdom | United States |
| Employees | 91128 | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3B | 43.0B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | VOD | BDX |
|---|---|---|
| Price | $15.68 | $170.09 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 13 |
| Target Price | N/A | ★ $186.00 |
| AVG Volume (30 Days) | ★ 5.1M | 1.7M |
| Earning Date | 06-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.24% | 2.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $11.47 | N/A |
| Revenue Next Year | $5.90 | $3.02 |
| P/E Ratio | ★ N/A | $674.88 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $11.00 | $140.11 |
| 52 Week High | $16.61 | $213.08 |
Technical Indicators
Market Signals| Indicator | VOD | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 56.55 | 65.87 |
| Support Level | $14.49 | $163.44 |
| Resistance Level | $15.85 | $196.05 |
| Average True Range (ATR) | 0.28 | 3.68 |
| MACD | 0.03 | 1.09 |
| Stochastic Oscillator | 45.98 | 89.66 |
Price Performance
Historical ComparisonAbout VOD Vodafone Group Plc
Vodafone operates mobile and fixed-line networks and businesses across Europe, Africa, and the Middle East. Its largest market is Germany, where it is the second mobile operator after Deutsche Telekom and owns two cable networks after acquiring Kabel Deutschland in 2013 and Liberty Global Germany in 2019. In the UK, Vodafone merged with CK Hutchison in 2024, consolidating the mobile market. It also divested its Spanish and Italian divisions in that same year, given their low returns on invested capital.
About BDX Becton Dickinson and Company
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.